Clash of the Titans: Exxon Mobil vs. Activist Investors in Landmark Climate Lawsuit
Exxon Mobil’s Legal Battle Against Activist Investors: The Fight for Corporate Responsibility and Shareholder Rights Exxon Mobil, one of the…
are you looking to grow your wealth and make smart investment decisions? Our money marketing website is here to help. Start maximizing your money today.
Exxon Mobil’s Legal Battle Against Activist Investors: The Fight for Corporate Responsibility and Shareholder Rights Exxon Mobil, one of the…
Canadian sportswear clothing band, Lululemon store in Hong Kong. Budrul Chukrut | Lightrocket | Getty Images Lululemon is launching its…
The logo for Merck & Co. is displayed on a screen at the New York Stock Exchange (NYSE) in New…
Wilson products at the Paragon Sports store in the Chelsea neighborhood of New York on Jan. 4, 2024. Jeenah Moon…
U.S. President Joe Biden speaks during a Rose Garden event at the White House to mark National Small Business Week…
Shares of Peloton plunged on Thursday after the fitness company warned investors it is still months away from growing sales…
Exxon Mobil’s Legal Battle Against Activist Investors: The Fight for Corporate Responsibility and Shareholder Rights Exxon Mobil, one of the world’s largest oil and gas companies, is continuing its lawsuit against activist investors despite the withdrawal of a shareholder proposal on climate change. This move sets the stage for a clash over what constitutes a…
Canadian sportswear clothing band, Lululemon store in Hong Kong. Budrul Chukrut | Lightrocket | Getty Images Lululemon is launching its first men’s footwear line and casual sneaker as the retailer looks for new avenues of growth in the increasingly crowded athletic apparel space, the company announced Thursday. The retailer is debuting its first casual sneaker,…
The logo for Merck & Co. is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, New York, U.S., November 17, 2021. Andrew Kelly | Reuters Merck on Thursday reported fourth-quarter revenue and adjusted earnings that topped estimates as it saw strong demand for its blockbuster cancer drug Keytruda…